Amorepacific Corporation

Seoul National University

Yong Deog Hong

Hyun Woo Jeong

Jin Sung Kim

Jun Seong Park

Gi Baeg Nam

Si Young Cho

Song Seok Shin

Byoung Young Woo

Young Ho Park

Dong Hyun Kim

Yung Hyup Joo

Kwanghyun Shin

Wonkyung Cho

Jinoh Chung

Kyoung Hee Byoun

Cheng Yi Zhang

Young Gyu Kang

Jin Kyu Choi

Nok Hyun Park

Kyung Min Lim

Miyoung Park

Yeon Su Jeong

Heung Soo Baek

Jon Hwan Lee

Hong-Ju Shin

Wonseok Park

Yong Joo Na

Hyungsu Kim

Seung Hyun Shin

Wanki Kim

Joonyoung Hwang

Il Hong Bae

A Young Kim

Moon Young Kim

Mi Young Park

Geum Ryong Park

Hyun Ju Jang

Myoyeon Kim

Seok Ha Lee

Jeong Min Ha

Yang Hui Park

The present disclosure relates to a composition for reducing body fat, which contains a green tea extract containing 4 wt % or more of gallocatechin gallate based on the total weight of the extract as an active ingredient, and a method for preparing the same. The composition according to the present disclosure provides a superior effect of reducing body fat as the green tea extract containing gallocatechin gallate is contained as an active ingredient. Accordingly, it can provide substances effective for treating obesity through various researches.

Composition for reducing body fat comprising green tea extract containing gallocatechin gallate as an active ingredient and manufacturing method thereof

The present disclosure relates to a new soybean variety containing epicatechin with high content and having antioxidant and antiaging activities, a method for producing the new soybean variety, a composition containing an extract of the new soybean variety as an active ingredient, a functional health food containing the new soybean variety, a method for producing epicatechin from the new soybean variety, and a method for producing a commodity plant product. The seed of the new soybean () variety according to an aspect of the present disclosure contains epicatechin with a high content of 2 wt % or more based on the total weight of an 80 wt % ethanol aqueous solution of seed extract, exhibits 2 times or higher antioxidant activity confirmed by DPPH radical-scavenging ability than the mother plant IT109098, and exhibits superior collagenase (matrix metalloproteinase-1, MMP-1) expression inhibition as compared to EGCG, which is known as an antiaging substance.

Soybean variety comprising high content of epicatechin

The present specification relates to (20S,24R)-6-O-β-D-glucopyranosyl(1→2)-β-D-glucopyranoside-dammar-3-one-20,24-epoxy-6a,12b,25-triol, which is a novel ginsenoside, a pharmaceutically acceptable salt thereof, a hydrate thereof or a solvate thereof. The novel ginsenoside exhibits excellent anti-inflammatory effects.

Ginsenoside and anti-inflammatory composition comprising same

The present disclosure relates to a nanoemulsion cosmetic composition including an oil phase and an aqueous phase, wherein the oil phase contains a ginseng nanopowder and an oil swollen by the ginseng nanopowder, the composition does not contain an additional surfactant, and the ginseng nanopowder is distributed uniformly in the composition. According to the present disclosure, there is provided a nanoemulsion cosmetic composition which contains a natural substance by containing a ginseng nanopowder and an oil swollen by the ginseng nanopowder in an oil phase and provides beneficial effect to skin.

Nanoemulsion cosmetic composition and process for preparing same

Shown are a particulate processed product of tea and a method for preparing the same. The particulate processed product of tea has a sphericity Svalue of a particle corresponding to 10% cumulative subdistribution in cumulative distribution measured for the sphericity of tea particles of 0.68 or greater. The processed product of tea is convenient to drink because it is readily wetted and dispersed in water. In addition, it can be easily packaged and used due to a low angle of repose and thus excellent flowability.

Processed products of tea and method for manufacturing the same

The present disclosure relates to a composition comprising (20S,24R)-6-O-&#x3b2;-D-glucopyranosyl(1&#x2192;2)-&#x3b2;-D-glucopyranoside-dammar-3-one-20,24-epoxy-6a,12b,25-triol, which is a novel ginsenoside, a pharmaceutically acceptable salt thereof, a hydrate thereof or a solvate thereof as an active ingredient. In addition, it relates to a method for preventing or improving menopausal symptoms, which comprises administering an effective amount of (20S,24R)-6-O-&#x3b2;-D-glucopyranosyl(1&#x2192;2)-&#x3b2;-D-glucopyranoside-dammar-3-one-20,24-epoxy-6a,12b,25-triol, a pharmaceutically acceptable salt thereof, a hydrate thereof or a solvate thereof to a subject in need thereof. The novel ginsenoside has a superior effect of preventing or improving menopausal symptoms with a low risk of breast cancer.

Composition for preventing or improving menopausal symptom comprising novel ginsenoside

The present disclosure relates to a method for preventing, alleviating, improving or treating female hormone regulation disorder or symptoms, which contains a green tea extract with contents of ingredients changed. Specifically, the method according to an aspect of the present disclosure includes a step of administering an effective amount of a green tea extract, which contains (&#x2212;)-gallocatechin gallate (GCG) and (&#x2212;)-epigallocatechin gallate (EGCG) at specific contents, to a subject in need thereof, and may exhibit an effect of preventing, alleviating, improving or treating female hormone regulation disorder or symptoms.

Method for preventing, alleviating, improving, or treating the female hormone controlling disorder syndrome or symptoms comprising a step of administering green tea extract which has modified amounts of ingredients

The present disclosure shows a particulate processed product of tea with quick dispersibility in water and a method for manufacturing a particulate processed product of tea. The processed product of tea comprises 20% by weight or less of fine powders having a particle diameter of 75 &#x3bc;m or less based on the total weight of the tea particles. The manufacturing method comprises the step of manufacturing tea particles using a fluid-bed rotor granulator having a rotor disc. The processed product of tea has quick wettability and dispersibility in water and thus is easy to drink. Also, the processed product of tea has a low angle of repose and thus has excellent flowability, so that it is easy to pack and use.

Processed products of tea with quick dispersibility in water and method for manufacturing processed products of tea

The present disclosure relates to a composition comprising (20S,24R)-6-O-&#x3b2;-D-glucopyranosyl(1&#x2192;2)-&#x3b2;-D-glucopyranoside-dammar-3-one-20,24-epoxy-6a,12b,25-triol, which is a novel ginsenoside, a pharmaceutically acceptable salt thereof, a hydrate thereof or a solvate thereof as an active ingredient. In addition, it relates to a method for improving skin elasticity or skin wrinkles, which comprises administering an effective amount of (20S,24R)-6-O-&#x3b2;-D-glucopyranosyl(1&#x2192;2)-&#x3b2;-D-glucopyranoside-dammar-3-one-20,24-epoxy-6a,12b,25-triol, a pharmaceutically acceptable salt thereof, a hydrate thereof or a solvate thereof to a subject in need thereof. The novel ginsenoside, a pharmaceutically acceptable salt thereof, a hydrate thereof or a solvate thereof has a superior effect of improving skin elasticity and skin wrinkles.

Composition for improving skin elasticity comprising novel ginsenoside

The present specification relates to a composition containing novel ginsenoside, (20S,24R)-6-O-&#x3b2;-D-glucopyranosyl(1&#x2192;2)-&#x3b2;-D-glucopyranoside-dammar-3-one-20,24-epoxy-6a,12b,25-triol, a pharmaceutically acceptable salt thereof, a hydrate or a solvate thereof as an active ingredient. The composition exhibits excellent effects in glycemic control, lipid metabolic control, cholesterol control, anti-obesity and blood circulation improvement.

Composition comprising novel ginsenoside

The present specification relates to a composition containing novel (20S,24R)-6-O-&#x3b2;-D-glucopyranosyl(1&#x2192;2)-&#x3b2;-D-glucopyranoside-dammar-3-one-20,24-epoxy-6a,12b,25-triol, a pharmaceutically acceptable salt thereof, a hydrate or a solvate thereof as an active ingredient. The composition exhibits an excellent exercise ability enhancing effect and anti-fatigue effect.

Composition for enhancing exercise ability or anti-fatigue comprising novel ginsenoside

The present invention relates to a cosmetic composition comprising a compound represented by Formula 1 below as an active ingredient. 

Cosmetics composition containing ginsenoside as active ingredient

The present specification relates to a composition containing novel (20S,24R)-6-O-&#x3b2;-D-glucopyranosyl(1&#x2192;2)-&#x3b2;-D-glucopyranoside-dammar-3-one-20,24-epoxy-6a,12b,25-triol, a pharmaceutically acceptable salt thereof, a hydrate or a solvate thereof as an active ingredient. The composition exhibits an excellent skin brightening effect.

Skin brightening composition comprising novel ginsenoside

Disclosed is a novel adamantine derivative compound, an isomer thereof, pharmaceutically acceptable salt thereof, prodrug thereof, hydrate thereof or a solvate thereof. Also disclosed is a method for preparing a novel adamantine derivative compound, an isomer thereof, pharmaceutically acceptable salt thereof, prodrug thereof, hydrate thereof or a solvate thereof. The novel adamantane derivative compound or the like has an excellent anti-androgenic effect.

Adamantane derivative compound

The present invention relates to a method for selectively producing compound K and compound Y, which are originally present in ginseng in a trace amount, from saponins of ginseng, and more specifically to a method capable of obtaining desired target compounds, that is, compound K and compound Y, in high yields, by treating saponins, obtained from ginseng, with particular enzymes to structurally convert the saponins.

Growing community of inventors

Yongin-si, South Korea

Yong Deog Hong